// App-Quantinova.ai

GW25-e1403 : Validation of CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients with or without application of oral anticoagulant: a meta-analysis of cohort studies

Researchers

Presenter

  • Zhu Wengen

Principal Investigators

  • Hong Kui

Medical Centers

  • Jiangxi Key Laboratory of Molecular Medicine, Jiangxi, 330006, China

  • Cardiology Department, the Second Affiliated Hospital of Nanchang University, Jiangxi, 330006, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved